Information Hub

Event
Partner
Milestone
Event
2017-12-29

02/02 ACT Genomics deomstrate the importance of NGS in lung cancer treatment

To search for more effective lung cancer treatment strategies, Taiwan Clinical Oncology Society conducts Taiwan Lung Cancer Oncologists meeting and invites ACT Genomics to introduce Next Generation Sequencing and our advantages in genetic testing.

Place:

Taipei

Event
2017-12-29

01/13 Let's turn genomics into actionable solutions for NET

The Digestive Endoscopy Society of Taiwan holds two NET medical seminars on 1/13 in Taichung for more discussions about the latest NET treatment strategy. ACT Genomics will share more about precision medicine in our display area and provide information of

Place:

Taichung

Event
2017-12-29

12/13 A new hero to save children from pediatric oncology

ACT Genomics would like to help cancer patients by our genetic testing, so we introduce precision medicine and the latest news in KK Woman's and Children's Hospital Pediatric Center to bring new hope to children's life

Place:

Singapore

Event
2017-12-29

12/07 ACT Genomics in biopharma summit

ACT Genomics shared our successful cases with pharma in a meeting in Hong Kong, and we aim to utilize our cutting-edge technology to open up new pages to the cancer drug development.

Place:

Hong Kong

Event
2017-12-29

12/06 ACT Genomics shared insights on diagnostic solutions in Frost& Sullivan web seminar

Global market research authority, Frost & Sullivan, held a webinar themed“Increased R&D Investments and Digitization Propel Growth of Diagnostic Solutions in Asia”. ACT Genomics Senior Vice President, Dr. Allen Lai shared his insights in the webinar.

Place:

Singapore

Partner
2017-12-05

ACT Genomics partners with Quark Biosciences to develop tumor micro-environment chip

ACT Genomics announces partnership with Quark Biosciences to develop tumor micro-environment chip (TME Chip) as a universal biomarker for cancer immunotherapy, aiming to increase the response rate by identifying suitable patients with precision.

Place:

Taipei

Event
2017-12-05

02/07-09 Join us at the "Future of Personalized and Precision Medicine" Conference in Singapore

Dr. Allen Lai, ACT Genomics’ senior VP, is honored to be a keynote speaker at the “Future of Personalized and Precision Medicine” conference in Singapore to speak on the topic of “The Reality and Challenges of Precision Medicine in Asia.”

Place:

Singapore

Partner
2017-11-01

ACT Genomics partners with ASLAN Pharmaceuticals in biomarker exploration for Varlitinib

ACT Genomics officially launched collaboration with ASLAN Pharmaceuticals as the biomarker exploration partner for Varlitinib in the global pivotal trial to investigate Varlitinib as a treatment for gastric cancer, biliary tract cancer, and metastatic col

Place:

Event
2017-11-01

12/09 Discover more about cancer of unknown primary in ACT Genomics PCMW

The third ACT Genomics Precision Cancer Medicine Workshop, held on 12/09 in Taipei Chang Yung-Fa Foundation, will focus on the case-sharing and treatment experiences of cancer of unknown primary

Place:

Taipei

Event
2017-11-01

12/07 Explore biomarker applications with ACT Genomics

ACT Genomics hosts a seminar theme“Biomarker for Immunotherapy, Cancer Vaccine and Translational Strategies", aiming to help biopharma find better ways to integrate biomarker into their research projects

Place:

Taipei